Brind.

Clinical trial sites are currently enrolling patients in the United States, United Kingdom, and Australia.

Steady: 0 in the last 7 days Updated oct 24

The latest in this situation

  1. Oxford has been designated as a second global site for a clinical trial, with Cushla Cooper leading clinical operations.

How it started

2 reports, 2 independent, last reported Aug 17. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Clinical trial sites are currently enrolling patients in the United States, United Kingdom, and Australia.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Oxford has been designated as a second global site for a clinical trial, with Cushla Cooper leading clinical operations.Sub-event
  2. FDA is involved in regulatory pathways utilizing Australian trial sites, including Alfred Health, Royal Adelaide Hospital, and Mackay Base Hospital.Sub-event
  3. Company begins clinical trials in the US, UK, and Australia.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped